EFPIA : European Sunshine Act for Pharmaceutical Companies

The EFPIA Code on the Disclosure of Transfers of Value from Pharmaceutical Companies to Healthcare Professionals and Healthcare Organisations
received its formal approval at the general assembly on 24-25 June 2013; it is required to be transposed into national Codes by 31 December 2013.

There are 3 levels of disclosure established: Aggregate, Individual HCO and Individual HCP:

• At an aggregate level : everything concerning clinical trials (phase 1 to 4) for donations and grants, sponsorships, events & hospitality and fees for services & consultancy.
• For individual HCO : Donations & Grants, Sponsorships, events & hospitality: registration fees; travel & accommodation; and associated ToV (Threshold of Visibility. Such as food, beverage & others exceeding threshold), Fees for service & consultancy
• For individual HCP : Same as HCO except fees for service and consultancy

The first disclosure will be made in 2016 for payments of 2015.